The average price target for First Tracks Biotherapeutics Inc is 39.00. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is 46.00 ,the lowest forecast is 31.00. The average price target represents N/A Increase from the current price of N/A.